PRINCIPIA BIOPHARMA INC. Marketable Securities (Current)
PRINCIPIA BIOPHARMA INC. had Marketable Securities (Current) of $146.05 million as of 2020-06-30, per its 10-Q filed 2020-08-06.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2020-08-06
- 2020-06-30: Marketable Securities, Current $146.05M.
- 2020-03-31: Marketable Securities, Current $252.04M.
- 2019-12-31: Marketable Securities, Current $276.04M.
- 2019-09-30: Marketable Securities, Current $121.29M.
| Period end | Marketable Securities, Current |
|---|---|
| 2020-06-30 | $146.05M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $252.04M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $276.04M 10-Q · filed 2020-08-06 |
| 2019-09-30 | $121.29M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $128.49M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $148.95M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $142.44M 10-K · filed 2020-03-10 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-19 |